SDGR | Schrödinger, Inc. Stock Overview

(Stock Exchange: NASDAQ)

Day's Range	19.01 - 19.84
52 Week Range	16.67 - 38.00
Beta	1.89
Implied Volatility	62.91%
IV Rank	31.68%
Day's Volume	816,497
Average Volume	704,544
Shares Outstanding	72,684,304
Market Cap	1,412,982,870
Sector	Healthcare
Industry	Medical - Healthcare Information Services
IPO Date	2020-02-06

Valuation
Profitability
Growth
Health
P/E Ratio	-7.93
Forward P/E Ratio	90.53
EPS	-2.45
1YR Price Target	45.00
Dividend Yield	N/A
Dividend Per Share	N/A
Dividend ExDate	N/A
Dividend PayDate	N/A
Employees	900
Country	USA
Website	SDGR

Schrodinger Inc is a healthcare-based software company. Its operating segments are Software and Drug discovery. Through the Software segment, the company is focused on selling software to transform drug discovery across the life sciences industry and customers in materials science industries. In the Drug discovery segment, it is engaged in generating revenue from a portfolio of preclinical and clinical programs, internally and through collaborations. Schrodinger generates revenue from the sales of software solutions and from research funding and milestone payments from its drug discovery collaborations.

SDGR's peers: AMWL, DOCS, GDRX, VEEV, GEHC, TDOC, TXG, PGNY, CERT, HQY, RCM, ACCD, SHLT

*Chart delayed

Analyzing fundamentals for SDGR we got that it has weak fundamentals where Valuation is considered to be significantly overvalued, Profitability is unacceptably poor, Growth is very bad and Health is weak. For more detailed analysis please see SDGR Fundamentals page.

Watching at SDGR technicals we can see that long-term trend is bearish, the same as bearish middle-term trend, as well as bearish short-term trend. More technicals details can be found on SDGR Technicals page.